Your session is about to expire
← Back to Search
Behavioural Intervention
Osteopathic Manipulative Treatment for Glaucoma (OMT/IOP Trial)
N/A
Waitlist Available
Led By Hollis H King, DO, PhD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-day and 1-week post-intervention or no intervention
Awards & highlights
OMT/IOP Trial Summary
This trial is studying how well osteopathic manipulative treatment (OMT) works in treating people with glaucoma.
Who is the study for?
Adults 18+ with ocular hypertension, glaucoma suspects, or primary open-angle glaucoma with IOP ≥20 mmHg. Candidates must not have visual field defects, abnormal optic nerve cupping, narrow angles in the eye, recent ocular surgery or trauma, and should not be on IOP lowering meds for at least 4 weeks prior.Check my eligibility
What is being tested?
The study tests if Osteopathic Manipulative Treatment (OMT) can lower intraocular pressure (IOP) in patients with high eye pressure related to glaucoma. It's a randomized trial aiming to provide data that could lead to larger trials if results are positive.See study design
What are the potential side effects?
While specific side effects of OMT are not detailed here, it generally involves manual therapy which may cause discomfort or minor pain post-treatment. Uncommonly there might be headaches or fatigue.
OMT/IOP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-day and 1-week post-intervention or no intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-day and 1-week post-intervention or no intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intraocular Pressure Change
OMT/IOP Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Osteopathic Manipulative Treatment (OMT)Experimental Treatment1 Intervention
Osteopathic manipulation involves a number of different manual (hands-on) techniques. These include muscle inhibition (applying pressure to a muscle to induce relaxation); myofascial release (applying pressure to the fascia and moving it toward/away from a strain); muscle energy stretch (contraction of a stretching muscle); counterstrain (shortening a strained muscle); facilitated positional release (moving a vertebra into a restriction and applying a gentle compression); osteopathy in the cranial field (balancing the cranial tissue); balanced ligamentous tension/ligamentous articular strain (moving a joint into ease to release tension in the ligament); one or all of these techniques may be used. Participants will be positioned on an exam table supine, seated, lateral decubitus, prone, or in their position of greatest comfort for the procedure.
Group II: No InterventionActive Control1 Intervention
Participants in the No Intervention arm will undergo the planned assessments, but not receive any intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Osteopathic Manipulative Treatment
2008
Completed Phase 4
~2530
Find a Location
Who is running the clinical trial?
University of California, San DiegoLead Sponsor
1,120 Previous Clinical Trials
1,521,379 Total Patients Enrolled
11 Trials studying Glaucoma
4,912 Patients Enrolled for Glaucoma
Hollis H King, DO, PhDPrincipal InvestigatorUniversity of California, San Diego
4 Previous Clinical Trials
159 Total Patients Enrolled
1 Trials studying Glaucoma
28 Patients Enrolled for Glaucoma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had a serious eye injury in the past six months.You are allergic to Latex, PABA, Proparacaine, or Fluorescein.You have any eye condition that makes it difficult to accurately measure eye pressure, such as keratoconus, cornea scarring, or conjunctiva issues.You have had an eye infection or inflammation in either eye within the past three months.You currently have a widespread infection that is causing fever or weakening your immune system.You have a history of severe eye inflammation that keeps coming back, like scleritis or uveitis.
Research Study Groups:
This trial has the following groups:- Group 1: Osteopathic Manipulative Treatment (OMT)
- Group 2: No Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are applications still being accepted for participation in this research?
"In accordance with clinicaltrials.gov, this study is not currently enrolling participants as it was last updated on September 30th 2022. However, there are 206 other medical trials actively searching for patients presently."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger